Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.

Blood - 15 Jul 2007

Passamonti Francesco, Randi Maria Luigia, Rumi Elisa, Pungolino Ester, Elena Chiara, Pietra Daniela, Scapin Margherita, Arcaini Luca, Tezza Fabiana, Moratti Remigio, Pascutto Cristiana, Fabris Fabrizio, Morra Enrica, Cazzola Mario, Lazzarino Mario

Abstract excerpt

Essential thrombocythemia (ET) may occur in women of childbearing age. To investigate the risk of pregnancy complications, we studied 103 pregnancies that occurred in 62 women with ET. The 2-tailed Fisher exact test showed that pregnancy outcome was independent from that of a previous pregnancy....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal Death
Share to Fetal Growth Retardation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Platelet Count

Share to Pre-Eclampsia

Share to Pregnancy Complications, Hematologic

Share to Pregnancy Complications, Neoplastic

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 17426257
DOI: 10.1182/blood-2007-01-071068

Genes

JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17426257-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation.PMID 17426257Read ↗

Impact of mutational status on pregnancy outcome in patients with essential thrombocytemiaSemantic proximity Read ↗

Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.Semantic proximity Read ↗

The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.Semantic proximity Read ↗

JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients.Semantic proximity Read ↗

JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients.Semantic proximity Read ↗

Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations.Semantic proximity Read ↗

Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation statusSemantic proximity Read ↗

Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia.Semantic proximity Read ↗

Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency.Semantic proximity Read ↗

Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.Semantic proximity Read ↗

Thrombophilia prevalence among women with placenta-mediated pregnancy complications.Semantic proximity Read ↗

Interferon therapy for pregnant patients with essential thrombocythemia in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.